Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

Each year, over 1.2 million Americans receive a cancer diagnosis, a journey that can be both overwhelming and daunting.

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...

New book exposes cancer diet myths, debunks misconceptions about fasting, sugar, and dairy, and advocates evidence-based nutrition to support patients through oncology treatment ...

As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and ...